Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions

C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on th...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 54; no. 2; pp. 396 - 402
Main Authors Park, Do-Sim, Kim, Dong, Hwang, Ki-Eun, Hwang, Yu-Ri, Park, Chul, Seol, Chang-Hwan, Cho, Kyung-Hwa, Kim, Byoung-Ryun, Park, Seong-Hoon, Jeong, Eun-Taik, Kim, Hak-Ryul
Format Journal Article
LanguageEnglish
Published Korea (South) Yonsei University College of Medicine 01.03.2013
연세대학교의과대학
Subjects
Online AccessGet full text
ISSN0513-5796
1976-2437
1976-2437
DOI10.3349/ymj.2013.54.2.396

Cover

Abstract C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on the role of CRP in pleural effusions. This study aimed to evaluate the diagnostic and prognostic value of pleural CRP (p-CRP) in lung cancer patients with malignant pleural effusion (MPE). Pleural effusion (PE) samples were collected from patients with MPE (68 lung cancers; 12 extrathoracic tumors), and from 68 patients with various benign conditions (31 with pneumonia; 37 with tuberculosis). Concentrations of p- and s-CRP were measured by enzyme-linked immunosorbent assay. CRP level in pleural fluid and its association with survival were examined. p-CRP levels correlated with s-CRP levels (r=0.82, p<0.0001). For the differential diagnosis of MPE and benign PE, the area under the receiver operating characteristic curve was greater for p-CRP (0.86) than for s-CRP (0.77). High p-CRP expression significantly correlated with shorter overall survival (p=0.006). P-CRP was independent prognostic factor significantly associated with overall survival on multivariated analysis (p=0.0001). The relative risk of death for lung cancer patients with high p-CRP levels was 3.909 (95% confidence interval, 2.000-7.639). P-CRP is superior to s-CRP in determining pleural fluid etiology. Quantitative measurement of p-CRP might be a useful complementary diagnostic and prognostic test for lung cancer patients with MPE.
AbstractList C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on the role of CRP in pleural effusions. This study aimed to evaluate the diagnostic and prognostic value of pleural CRP (p-CRP) in lung cancer patients with malignant pleural effusion (MPE). Pleural effusion (PE) samples were collected from patients with MPE (68 lung cancers; 12 extrathoracic tumors), and from 68 patients with various benign conditions (31 with pneumonia; 37 with tuberculosis). Concentrations of p- and s-CRP were measured by enzyme-linked immunosorbent assay. CRP level in pleural fluid and its association with survival were examined. p-CRP levels correlated with s-CRP levels (r=0.82, p<0.0001). For the differential diagnosis of MPE and benign PE, the area under the receiver operating characteristic curve was greater for p-CRP (0.86) than for s-CRP (0.77). High p-CRP expression significantly correlated with shorter overall survival (p=0.006). P-CRP was independent prognostic factor significantly associated with overall survival on multivariated analysis (p=0.0001). The relative risk of death for lung cancer patients with high p-CRP levels was 3.909 (95% confidence interval, 2.000-7.639). P-CRP is superior to s-CRP in determining pleural fluid etiology. Quantitative measurement of p-CRP might be a useful complementary diagnostic and prognostic test for lung cancer patients with MPE.
Purpose: C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on the role of CRP in pleural effusions. This study aimed to evaluate the diagnostic and prognostic value of pleural CRP (p-CRP) in lung cancer patients with malignant pleural effusion (MPE). Materials and Methods: Pleural effusion (PE) samples were collected from patients with MPE (68 lung cancers; 12 extrathoracic tumors), and from 68 patients with various benign conditions (31 with pneumonia; 37 with tuberculosis). Concentrations of p- and s-CRP were measured by enzyme-linked immunosorbent assay. CRP level in pleural fluid and its association with survival were examined. Results: p-CRP levels correlated with s-CRP levels (r=0.82, p<0.0001). For the differential diagnosis of MPE and benign PE, the area under the receiver operating characteristic curve was greater for p-CRP (0.86) than for s-CRP (0.77). High p-CRP expression significantly correlated with shorter overall survival (p=0.006). P-CRP was independent prognostic factor significantly associated with overall survival on multivariated analysis (p=0.0001). The relative risk of death for lung cancer patients with high p-CRP levels was 3.909 (95% confidence interval, 2.000-7.639). Conclusion: P-CRP is superior to s-CRP in determining pleural fluid etiology. Quantitative measurement of p-CRP might be a useful complementary diagnostic and prognostic test for lung cancer patients with MPE. KCI Citation Count: 4
C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on the role of CRP in pleural effusions. This study aimed to evaluate the diagnostic and prognostic value of pleural CRP (p-CRP) in lung cancer patients with malignant pleural effusion (MPE).PURPOSEC-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be associated with independent prognostic factors for survival in patients with advanced lung cancer. However, only few studies have focused on the role of CRP in pleural effusions. This study aimed to evaluate the diagnostic and prognostic value of pleural CRP (p-CRP) in lung cancer patients with malignant pleural effusion (MPE).Pleural effusion (PE) samples were collected from patients with MPE (68 lung cancers; 12 extrathoracic tumors), and from 68 patients with various benign conditions (31 with pneumonia; 37 with tuberculosis). Concentrations of p- and s-CRP were measured by enzyme-linked immunosorbent assay. CRP level in pleural fluid and its association with survival were examined.MATERIALS AND METHODSPleural effusion (PE) samples were collected from patients with MPE (68 lung cancers; 12 extrathoracic tumors), and from 68 patients with various benign conditions (31 with pneumonia; 37 with tuberculosis). Concentrations of p- and s-CRP were measured by enzyme-linked immunosorbent assay. CRP level in pleural fluid and its association with survival were examined.p-CRP levels correlated with s-CRP levels (r=0.82, p<0.0001). For the differential diagnosis of MPE and benign PE, the area under the receiver operating characteristic curve was greater for p-CRP (0.86) than for s-CRP (0.77). High p-CRP expression significantly correlated with shorter overall survival (p=0.006). P-CRP was independent prognostic factor significantly associated with overall survival on multivariated analysis (p=0.0001). The relative risk of death for lung cancer patients with high p-CRP levels was 3.909 (95% confidence interval, 2.000-7.639).RESULTSp-CRP levels correlated with s-CRP levels (r=0.82, p<0.0001). For the differential diagnosis of MPE and benign PE, the area under the receiver operating characteristic curve was greater for p-CRP (0.86) than for s-CRP (0.77). High p-CRP expression significantly correlated with shorter overall survival (p=0.006). P-CRP was independent prognostic factor significantly associated with overall survival on multivariated analysis (p=0.0001). The relative risk of death for lung cancer patients with high p-CRP levels was 3.909 (95% confidence interval, 2.000-7.639).P-CRP is superior to s-CRP in determining pleural fluid etiology. Quantitative measurement of p-CRP might be a useful complementary diagnostic and prognostic test for lung cancer patients with MPE.CONCLUSIONP-CRP is superior to s-CRP in determining pleural fluid etiology. Quantitative measurement of p-CRP might be a useful complementary diagnostic and prognostic test for lung cancer patients with MPE.
Author Kim, Dong
Park, Chul
Park, Do-Sim
Kim, Byoung-Ryun
Cho, Kyung-Hwa
Park, Seong-Hoon
Seol, Chang-Hwan
Hwang, Yu-Ri
Kim, Hak-Ryul
Jeong, Eun-Taik
Hwang, Ki-Eun
AuthorAffiliation 4 Department of Radiology, Wonkwang University School of Medicine, Iksan, Korea
1 Department of Laboratory Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
3 Department of Obstetrics & Gynecology, Wonkwang University School of Medicine, Iksan, Korea
2 Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
AuthorAffiliation_xml – name: 4 Department of Radiology, Wonkwang University School of Medicine, Iksan, Korea
– name: 3 Department of Obstetrics & Gynecology, Wonkwang University School of Medicine, Iksan, Korea
– name: 1 Department of Laboratory Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– name: 2 Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
Author_xml – sequence: 1
  givenname: Do-Sim
  surname: Park
  fullname: Park, Do-Sim
  organization: Department of Laboratory Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 2
  givenname: Dong
  surname: Kim
  fullname: Kim, Dong
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 3
  givenname: Ki-Eun
  surname: Hwang
  fullname: Hwang, Ki-Eun
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 4
  givenname: Yu-Ri
  surname: Hwang
  fullname: Hwang, Yu-Ri
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 5
  givenname: Chul
  surname: Park
  fullname: Park, Chul
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 6
  givenname: Chang-Hwan
  surname: Seol
  fullname: Seol, Chang-Hwan
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 7
  givenname: Kyung-Hwa
  surname: Cho
  fullname: Cho, Kyung-Hwa
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 8
  givenname: Byoung-Ryun
  surname: Kim
  fullname: Kim, Byoung-Ryun
  organization: Department of Obstetrics & Gynecology, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 9
  givenname: Seong-Hoon
  surname: Park
  fullname: Park, Seong-Hoon
  organization: Department of Radiology, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 10
  givenname: Eun-Taik
  surname: Jeong
  fullname: Jeong, Eun-Taik
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 11
  givenname: Hak-Ryul
  surname: Kim
  fullname: Kim, Hak-Ryul
  organization: Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23364973$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001745366$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFUcFu1DAQtVAR3RY-gAvykUuCYyd2fEGqlkIrLWJVCldr4thbt1l7Gyet9syP1-nSVeEAkqWRPO_Nm_fmCB344A1CbwuSM1bKD9v1dU5JwfKqzGnOJH-BZoUUPKMlEwdoRqqCZZWQ_BAdxXhNCBUFoa_QIWWMl1KwGfr1ycHKhzg4jX9CNxoMvsXLPjx9fncr76zT4LXBweJlZ8YeOjzPLgzowd2ZCT0Y53F6i9Gv8HzC9ngJgzN-iPjeDVf4K3RpEvhhP-HU2jG64ONr9NJCF82b3_UY_fh8ejk_yxbfvpzPTxaZLqtyyKpSNsAFobTkrZCUQFm3otDWCFEnZ6ZpoLEg68qyikJRt9BwbgjnVgpqODtG73dzfW_VjXYqgHusq6BuenVycXmuGCtoTRKU7qCj38D2HrpObXq3hn6rCqKm8FUKX03hq6pUVKXwE-njjrQZm7VpdTKffO6Jk9qfHe-ukvadYpWopHy24KYPt6OJg1q7qE3XgTdhjCqtxgQj5HHBd8-19iJPl00AsQPoPsTYG6u0G9JFwiTtun_aKP5i_t_6A0Nlyyw
CitedBy_id crossref_primary_10_1097_MD_0000000000031027
crossref_primary_10_4103_1687_8426_198999
crossref_primary_10_3389_fonc_2021_777930
crossref_primary_10_1158_1055_9965_EPI_24_0713
crossref_primary_10_1186_s13019_019_0981_0
crossref_primary_10_3389_fonc_2022_882900
crossref_primary_10_3390_diagnostics14131428
crossref_primary_10_3892_etm_2014_1503
Cites_doi 10.1038/sj.bjc.6690807
10.1038/nature01322
10.1056/NEJMra0805239
10.1016/j.ejim.2006.12.001
10.1016/j.lungcan.2007.02.022
10.1182/blood.V85.3.765.bloodjournal853765
10.1097/JTO.0b013e31811f4703
10.1007/s11912-002-0023-1
10.1136/thx.2007.077958
10.1016/S0147-0272(81)80012-8
10.1378/chest.122.3.1037
10.1038/sj.bjc.6601242
10.1097/JTO.0b013e3181da78f9
10.1183/09031936.97.10020476
10.1111/j.1440-1843.2003.00521.x
10.1172/JCI200318921
10.1136/jech.2006.051292
10.1158/1078-0432.CCR-07-1044
10.1378/chest.107.4.1028
10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y
10.1053/rmed.1999.0759
10.1111/j.1523-1755.2005.00666.x
10.1038/nature07205
10.1378/chest.128.5.3291
10.1002/cyto.b.10046
10.1038/sj.bjc.6600466
10.4046/trd.2005.59.6.625
10.1002/cncr.20976
10.4143/crt.2011.43.3.176
10.1002/jcla.20208
10.1183/09031936.97.10051125
10.1016/S0002-9610(98)00204-9
ContentType Journal Article
Copyright Copyright: Yonsei University College of Medicine 2013 2013
Copyright_xml – notice: Copyright: Yonsei University College of Medicine 2013 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.3349/ymj.2013.54.2.396
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1976-2437
EndPage 402
ExternalDocumentID oai_kci_go_kr_ARTI_331280
10.3349/ymj.2013.54.2.396
PMC3575996
23364973
10_3349_ymj_2013_54_2_396
Genre Evaluation Studies
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
123
29R
2WC
36B
5-W
53G
5RE
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
CS3
DIK
DU5
E3Z
EBD
EF.
EMB
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
L7B
M48
MK0
O5R
O5S
OK1
OVT
P2P
PGMZT
RNS
RPM
SV3
TR2
X7M
XSB
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c454t-549ba6702246d7920a48d71cfe778271ebbabfa985f352a18dab66e066f972e63
IEDL.DBID M48
ISSN 0513-5796
1976-2437
IngestDate Sun Mar 09 07:54:39 EDT 2025
Wed Aug 20 00:00:25 EDT 2025
Thu Aug 21 18:36:59 EDT 2025
Fri Jul 11 04:51:13 EDT 2025
Thu Apr 03 07:03:49 EDT 2025
Tue Jul 01 04:02:10 EDT 2025
Thu Apr 24 23:06:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c454t-549ba6702246d7920a48d71cfe778271ebbabfa985f352a18dab66e066f972e63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
Do-Sim Park and Dong Kim contributed equally to this work.
http://www.eymj.org/Synapse/Data/PDFData/0069YMJ/ymj-54-396.pdf
G704-000409.2013.54.2.023
OpenAccessLink https://proxy.k.utb.cz/login?url=http://eymj.org/Synapse/Data/PDFData/0069YMJ/ymj-54-396.pdf
PMID 23364973
PQID 1283730080
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_331280
unpaywall_primary_10_3349_ymj_2013_54_2_396
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3575996
proquest_miscellaneous_1283730080
pubmed_primary_23364973
crossref_citationtrail_10_3349_ymj_2013_54_2_396
crossref_primary_10_3349_ymj_2013_54_2_396
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Yonsei medical journal
PublicationTitleAlternate Yonsei Med J
PublicationYear 2013
Publisher Yonsei University College of Medicine
연세대학교의과대학
Publisher_xml – name: Yonsei University College of Medicine
– name: 연세대학교의과대학
References Memon (10.3349/ymj.2013.54.2.396_ref1) 1981; 5
Duffy (10.3349/ymj.2013.54.2.396_ref9) 2007; 18
Pelliniemi (10.3349/ymj.2013.54.2.396_ref20) 1995; 85
Mahmoud (10.3349/ymj.2013.54.2.396_ref13) 2002; 4
Yilmaz Turay (10.3349/ymj.2013.54.2.396_ref18) 2000; 94
Heikkilä (10.3349/ymj.2013.54.2.396_ref30) 2007; 61
Light (10.3349/ymj.2013.54.2.396_ref25) 1997; 10
Liang (10.3349/ymj.2013.54.2.396_ref8) 2008; 63
Chierakul (10.3349/ymj.2013.54.2.396_ref27) 2004; 9
Korppi (10.3349/ymj.2013.54.2.396_ref15) 1997; 10
Chiang (10.3349/ymj.2013.54.2.396_ref12) 2008; 359
Forrest (10.3349/ymj.2013.54.2.396_ref34) 2003; 89
Castaño Vidriales (10.3349/ymj.2013.54.2.396_ref17) 1992; 1
Brundage (10.3349/ymj.2013.54.2.396_ref33) 2002; 122
O'Dowd (10.3349/ymj.2013.54.2.396_ref35) 2010; 5
Kim (10.3349/ymj.2013.54.2.396_ref28) 2011; 43
Nozoe (10.3349/ymj.2013.54.2.396_ref22) 1998; 176
Smith (10.3349/ymj.2013.54.2.396_ref16) 1995; 107
Mantovani (10.3349/ymj.2013.54.2.396_ref11) 2008; 454
Jabs (10.3349/ymj.2013.54.2.396_ref21) 2005; 68
Miédougé (10.3349/ymj.2013.54.2.396_ref5) 1999; 81
Botana-Rial (10.3349/ymj.2013.54.2.396_ref29) 2011; 57
Papageorgiou (10.3349/ymj.2013.54.2.396_ref26) 2005; 128
Scott (10.3349/ymj.2013.54.2.396_ref31) 2002; 87
Hefler (10.3349/ymj.2013.54.2.396_ref23) 2008; 14
Søyseth (10.3349/ymj.2013.54.2.396_ref32) 2007; 57
Fiegl (10.3349/ymj.2013.54.2.396_ref3) 2003; 55
Ferrer (10.3349/ymj.2013.54.2.396_ref4) 1999; 86
Coussens (10.3349/ymj.2013.54.2.396_ref10) 2002; 420
Pepys (10.3349/ymj.2013.54.2.396_ref14) 2003; 111
Hara (10.3349/ymj.2013.54.2.396_ref19) 2007; 27
Postmus (10.3349/ymj.2013.54.2.396_ref2) 2007; 2
Kim (10.3349/ymj.2013.54.2.396_ref7) 2005; 59
Gu (10.3349/ymj.2013.54.2.396_ref6) 2007; 21
Hashimoto (10.3349/ymj.2013.54.2.396_ref24) 2005; 103
14982604 - Respirology. 2004 Mar;9(1):66-9
10868705 - Respir Med. 2000 May;94(5):432-5
22022295 - Cancer Res Treat. 2011 Sep;43(3):176-80
12949962 - Cytometry B Clin Cytom. 2003 Sep;55(1):60-2
16221209 - Kidney Int. 2005 Nov;68(5):2103-10
16304274 - Chest. 2005 Nov;128(5):3291-7
7530507 - Blood. 1995 Feb 1;85(3):765-71
12966420 - Br J Cancer. 2003 Sep 15;89(6):1028-30
18245530 - Clin Cancer Res. 2008 Feb 1;14(3):710-4
12490959 - Nature. 2002 Dec 19-26;420(6917):860-7
10576665 - Br J Cancer. 1999 Nov;81(6):1059-65
1341445 - Eur J Med. 1992 Jul-Aug;1(4):201-7
20453690 - J Thorac Oncol. 2010 Jul;5(7):988-92
6263549 - Curr Probl Cancer. 1981 Feb;5(8):1-30
12813013 - J Clin Invest. 2003 Jun;111(12):1805-12
12226051 - Chest. 2002 Sep;122(3):1037-57
10526277 - Cancer. 1999 Oct 15;86(8):1488-95
21755828 - Clin Lab. 2011;57(5-6):373-8
11937016 - Curr Oncol Rep. 2002 May;4(3):250-5
17699539 - J Epidemiol Community Health. 2007 Sep;61(9):824-33
18022924 - J Clin Lab Anal. 2007;21(6):398-405
17695486 - Anticancer Res. 2007 Jul-Aug;27(4C):3001-4
17762334 - J Thorac Oncol. 2007 Aug;2(8):686-93
12177792 - Br J Cancer. 2002 Jul 29;87(3):264-7
9042652 - Eur Respir J. 1997 Feb;10(2):476-81
9817250 - Am J Surg. 1998 Oct;176(4):335-8
19109576 - N Engl J Med. 2008 Dec 25;359(26):2814-23
9163657 - Eur Respir J. 1997 May;10(5):1125-9
17462788 - Lung Cancer. 2007 Aug;57(2):152-8
18650914 - Nature. 2008 Jul 24;454(7203):436-44
15779015 - Cancer. 2005 May 1;103(9):1856-64
17449388 - Eur J Intern Med. 2007 May;18(3):175-84
7705110 - Chest. 1995 Apr;107(4):1028-31
17573438 - Thorax. 2008 Jan;63(1):35-41
References_xml – volume: 81
  start-page: 1059
  year: 1999
  ident: 10.3349/ymj.2013.54.2.396_ref5
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690807
– volume: 420
  start-page: 860
  year: 2002
  ident: 10.3349/ymj.2013.54.2.396_ref10
  publication-title: Nature
  doi: 10.1038/nature01322
– volume: 359
  start-page: 2814
  year: 2008
  ident: 10.3349/ymj.2013.54.2.396_ref12
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0805239
– volume: 18
  start-page: 175
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref9
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2006.12.001
– volume: 57
  start-page: 152
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref32
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2007.02.022
– volume: 85
  start-page: 765
  year: 1995
  ident: 10.3349/ymj.2013.54.2.396_ref20
  publication-title: Blood
  doi: 10.1182/blood.V85.3.765.bloodjournal853765
– volume: 2
  start-page: 686
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref2
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e31811f4703
– volume: 4
  start-page: 250
  year: 2002
  ident: 10.3349/ymj.2013.54.2.396_ref13
  publication-title: Curr Oncol Rep
  doi: 10.1007/s11912-002-0023-1
– volume: 63
  start-page: 35
  year: 2008
  ident: 10.3349/ymj.2013.54.2.396_ref8
  publication-title: Thorax
  doi: 10.1136/thx.2007.077958
– volume: 1
  start-page: 201
  year: 1992
  ident: 10.3349/ymj.2013.54.2.396_ref17
  publication-title: Eur J Med
– volume: 5
  start-page: 1
  year: 1981
  ident: 10.3349/ymj.2013.54.2.396_ref1
  publication-title: Curr Probl Cancer
  doi: 10.1016/S0147-0272(81)80012-8
– volume: 122
  start-page: 1037
  year: 2002
  ident: 10.3349/ymj.2013.54.2.396_ref33
  publication-title: Chest
  doi: 10.1378/chest.122.3.1037
– volume: 57
  start-page: 373
  year: 2011
  ident: 10.3349/ymj.2013.54.2.396_ref29
  publication-title: Clin Lab
– volume: 89
  start-page: 1028
  year: 2003
  ident: 10.3349/ymj.2013.54.2.396_ref34
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601242
– volume: 5
  start-page: 988
  year: 2010
  ident: 10.3349/ymj.2013.54.2.396_ref35
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3181da78f9
– volume: 10
  start-page: 476
  year: 1997
  ident: 10.3349/ymj.2013.54.2.396_ref25
  publication-title: Eur Respir J
  doi: 10.1183/09031936.97.10020476
– volume: 9
  start-page: 66
  year: 2004
  ident: 10.3349/ymj.2013.54.2.396_ref27
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2003.00521.x
– volume: 111
  start-page: 1805
  year: 2003
  ident: 10.3349/ymj.2013.54.2.396_ref14
  publication-title: J Clin Invest
  doi: 10.1172/JCI200318921
– volume: 61
  start-page: 824
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref30
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.2006.051292
– volume: 14
  start-page: 710
  year: 2008
  ident: 10.3349/ymj.2013.54.2.396_ref23
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-1044
– volume: 107
  start-page: 1028
  year: 1995
  ident: 10.3349/ymj.2013.54.2.396_ref16
  publication-title: Chest
  doi: 10.1378/chest.107.4.1028
– volume: 27
  start-page: 3001
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref19
  publication-title: Anticancer Res
– volume: 86
  start-page: 1488
  year: 1999
  ident: 10.3349/ymj.2013.54.2.396_ref4
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y
– volume: 94
  start-page: 432
  year: 2000
  ident: 10.3349/ymj.2013.54.2.396_ref18
  publication-title: Respir Med
  doi: 10.1053/rmed.1999.0759
– volume: 68
  start-page: 2103
  year: 2005
  ident: 10.3349/ymj.2013.54.2.396_ref21
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2005.00666.x
– volume: 454
  start-page: 436
  year: 2008
  ident: 10.3349/ymj.2013.54.2.396_ref11
  publication-title: Nature
  doi: 10.1038/nature07205
– volume: 128
  start-page: 3291
  year: 2005
  ident: 10.3349/ymj.2013.54.2.396_ref26
  publication-title: Chest
  doi: 10.1378/chest.128.5.3291
– volume: 55
  start-page: 60
  year: 2003
  ident: 10.3349/ymj.2013.54.2.396_ref3
  publication-title: Cytometry B Clin Cytom
  doi: 10.1002/cyto.b.10046
– volume: 87
  start-page: 264
  year: 2002
  ident: 10.3349/ymj.2013.54.2.396_ref31
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6600466
– volume: 59
  start-page: 625
  year: 2005
  ident: 10.3349/ymj.2013.54.2.396_ref7
  publication-title: Tuberc Respir Dis
  doi: 10.4046/trd.2005.59.6.625
– volume: 103
  start-page: 1856
  year: 2005
  ident: 10.3349/ymj.2013.54.2.396_ref24
  publication-title: Cancer
  doi: 10.1002/cncr.20976
– volume: 43
  start-page: 176
  year: 2011
  ident: 10.3349/ymj.2013.54.2.396_ref28
  publication-title: Cancer Res Treat
  doi: 10.4143/crt.2011.43.3.176
– volume: 21
  start-page: 398
  year: 2007
  ident: 10.3349/ymj.2013.54.2.396_ref6
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.20208
– volume: 10
  start-page: 1125
  year: 1997
  ident: 10.3349/ymj.2013.54.2.396_ref15
  publication-title: Eur Respir J
  doi: 10.1183/09031936.97.10051125
– volume: 176
  start-page: 335
  year: 1998
  ident: 10.3349/ymj.2013.54.2.396_ref22
  publication-title: Am J Surg
  doi: 10.1016/S0002-9610(98)00204-9
– reference: 16221209 - Kidney Int. 2005 Nov;68(5):2103-10
– reference: 15779015 - Cancer. 2005 May 1;103(9):1856-64
– reference: 7705110 - Chest. 1995 Apr;107(4):1028-31
– reference: 12490959 - Nature. 2002 Dec 19-26;420(6917):860-7
– reference: 11937016 - Curr Oncol Rep. 2002 May;4(3):250-5
– reference: 12966420 - Br J Cancer. 2003 Sep 15;89(6):1028-30
– reference: 12813013 - J Clin Invest. 2003 Jun;111(12):1805-12
– reference: 10526277 - Cancer. 1999 Oct 15;86(8):1488-95
– reference: 17449388 - Eur J Intern Med. 2007 May;18(3):175-84
– reference: 16304274 - Chest. 2005 Nov;128(5):3291-7
– reference: 19109576 - N Engl J Med. 2008 Dec 25;359(26):2814-23
– reference: 12949962 - Cytometry B Clin Cytom. 2003 Sep;55(1):60-2
– reference: 17762334 - J Thorac Oncol. 2007 Aug;2(8):686-93
– reference: 10868705 - Respir Med. 2000 May;94(5):432-5
– reference: 12226051 - Chest. 2002 Sep;122(3):1037-57
– reference: 7530507 - Blood. 1995 Feb 1;85(3):765-71
– reference: 18022924 - J Clin Lab Anal. 2007;21(6):398-405
– reference: 9163657 - Eur Respir J. 1997 May;10(5):1125-9
– reference: 9042652 - Eur Respir J. 1997 Feb;10(2):476-81
– reference: 18245530 - Clin Cancer Res. 2008 Feb 1;14(3):710-4
– reference: 6263549 - Curr Probl Cancer. 1981 Feb;5(8):1-30
– reference: 14982604 - Respirology. 2004 Mar;9(1):66-9
– reference: 1341445 - Eur J Med. 1992 Jul-Aug;1(4):201-7
– reference: 17699539 - J Epidemiol Community Health. 2007 Sep;61(9):824-33
– reference: 22022295 - Cancer Res Treat. 2011 Sep;43(3):176-80
– reference: 21755828 - Clin Lab. 2011;57(5-6):373-8
– reference: 10576665 - Br J Cancer. 1999 Nov;81(6):1059-65
– reference: 12177792 - Br J Cancer. 2002 Jul 29;87(3):264-7
– reference: 18650914 - Nature. 2008 Jul 24;454(7203):436-44
– reference: 9817250 - Am J Surg. 1998 Oct;176(4):335-8
– reference: 20453690 - J Thorac Oncol. 2010 Jul;5(7):988-92
– reference: 17462788 - Lung Cancer. 2007 Aug;57(2):152-8
– reference: 17695486 - Anticancer Res. 2007 Jul-Aug;27(4C):3001-4
– reference: 17573438 - Thorax. 2008 Jan;63(1):35-41
SSID ssj0027102
Score 2.026446
Snippet C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown to be...
Purpose: C-reactive protein (CRP) has been implicated in various inflammatory and advanced malignant states. Increased serum CRP (s-CRP) levels have been shown...
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 396
SubjectTerms C-Reactive Protein - metabolism
Enzyme-Linked Immunosorbent Assay
Humans
Lung Neoplasms - diagnosis
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Multivariate Analysis
Original
Pleural Effusion, Malignant - diagnosis
Pleural Effusion, Malignant - metabolism
Pleural Effusion, Malignant - pathology
Predictive Value of Tests
Prognosis
Survival Analysis
의학일반
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtCtte9t01-0KDPW0osSxZih5L0tCVpYR1GS0MhGRLWZbUCUnMyF73j09nJ2GhY2MDg8A6W5b9s3S6O_0OodfCu8i1Ik-4jRXh0iqifEaJp0ZxaqjxHuyQvXNxOuBnl8nlHtqkuXOr66-l__5ilZvZwjU7Zmma_U63LIFW96p31gxCJOGEKdGYZX4fHQjwLtXQweC8f3wFY29CGYFdlqVPWQoCtHuVT5MxruAGENXFGmBWCct-sTMr7edz_zuF82bc5O0in5nVNzOZ_DIpde-hz5utPVUsyrhRLG0j_X6T6fF_-nsf3V0rq_i4QtcDtOfyh-hWb-2Of4R-dKpAvVCNP5lJ4bDJM9yfTzcnL0bDHGKRAFp46nF_4oDmA7fJB2fKkRakIeEmDsf7MPDgNsjOcb_ie11gMBTjXlgtDCFkZ3uHE-8LMPQtHqNB9-Rj-5SsszqQlCd8GTqirBGyZLLLpIojw1uZpKl3MmgrkjprjfVGtRIflENDW5mxQrigGnklYyfYIarl09wdIRx0ExapLFLOM255bKVJDPWKxtS3VOrqKNp8VZ2uKc8h88ZEh6UPAEGHN6sBCDrhOtbhBdfRm-0ls4rv40_CrwJU9DgdaWDphnI41eO5DmuRd-GaMPdHQWYDJB3-XHDHmNxNi4WmQDzEQGWvoycVsLZNxowJriSrI7kDua0AtLdbk4--lOzgDFKuwrO93YLz7z15-k_Sz9CduMwKAqF4z1FtOS_ci6CbLe3L9T_4E3DENmM
  priority: 102
  providerName: Unpaywall
Title Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions
URI https://www.ncbi.nlm.nih.gov/pubmed/23364973
https://www.proquest.com/docview/1283730080
https://pubmed.ncbi.nlm.nih.gov/PMC3575996
http://eymj.org/Synapse/Data/PDFData/0069YMJ/ymj-54-396.pdf
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001745366
UnpaywallVersion publishedVersion
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Yonsei Medical Journal, 2013, 54(2), , pp.396-402
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: KQ8
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: DOA
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: DIK
  dateStart: 19600101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: GX1
  dateStart: 19600101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: 5-W
  dateStart: 19600101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: RPM
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1976-2437
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0027102
  issn: 1976-2437
  databaseCode: M48
  dateStart: 20050201
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfWTQJeEJ-jfFRG4gmUEcfOhx8QmsqmgehUAYXxZNmJXcpCMtJG0Gf-ce6StFBRAVKkSPE5jn1n-3fnyx0hjyJnfZv4zhMmkJ6IjfSky5jnmJaCaaadQzvk6DQ6mYhXZ-HZDlmlt-oGcL5VtcN8UpMqP_j-dfkcJvwz1Di5kE-XXz6jjxY_QCMJKPFRj-zBxhSgkI9E8kv_Yo0LIogh9_AXzPaQc_srNrapXlG5bQj0T0fKy3VxoZffdJ7_tksdXyNXO3hJD1t5uE52bHGDXBp1B-g3yY8XrWsdFNP3Oq8t1UVGx1W5evh2Ni3QewiFgZaOjnOLgTno0HtjdbM2IjWmyKRwvYalgg6RtqLjNkLrnKJpl44A30_RyWb9hiPnajTNzW-RyfHRu-GJ1-Vh8FIRioUHKqTRUdzEnstiGfhaJFnMUmdjwBcxs8Zo47RMQgdwTrMk0yaKLIAZJ-PARvw22S3Kwt4hFNAE92XmS-u4MCIwsQ41c5IFzCUytX3ir4ZdpV2QcsyVkStQVpBTCjilkFMqFCpQwKk-ebyuctFG6Pgb8UPgpTpPZwrjauN9WqrzSoH28BLqwG7tA82K0wrmGh6g6MKW9VwxDBXEEWT3yX7L-XWTAeeRkDHvk3hDJtYE2N5mSTH71MTz5pgkFb_tyVp6_t2Tu__Rk3vkStBk70CXuftkd1HV9gFgqIUZkF7ofRg0FohBM0sGZG9yOj78-BPDAR1o
linkProvider Scholars Portal
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtCtte9t01-0KDPW0osSxZih5L0tCVpYR1GS0MhGRLWZbUCUnMyF73j09nJ2GhY2MDg8A6W5b9s3S6O_0OodfCu8i1Ik-4jRXh0iqifEaJp0ZxaqjxHuyQvXNxOuBnl8nlHtqkuXOr66-l__5ilZvZwjU7Zmma_U63LIFW96p31gxCJOGEKdGYZX4fHQjwLtXQweC8f3wFY29CGYFdlqVPWQoCtHuVT5MxruAGENXFGmBWCct-sTMr7edz_zuF82bc5O0in5nVNzOZ_DIpde-hz5utPVUsyrhRLG0j_X6T6fF_-nsf3V0rq_i4QtcDtOfyh-hWb-2Of4R-dKpAvVCNP5lJ4bDJM9yfTzcnL0bDHGKRAFp46nF_4oDmA7fJB2fKkRakIeEmDsf7MPDgNsjOcb_ie11gMBTjXlgtDCFkZ3uHE-8LMPQtHqNB9-Rj-5SsszqQlCd8GTqirBGyZLLLpIojw1uZpKl3MmgrkjprjfVGtRIflENDW5mxQrigGnklYyfYIarl09wdIRx0ExapLFLOM255bKVJDPWKxtS3VOrqKNp8VZ2uKc8h88ZEh6UPAEGHN6sBCDrhOtbhBdfRm-0ls4rv40_CrwJU9DgdaWDphnI41eO5DmuRd-GaMPdHQWYDJB3-XHDHmNxNi4WmQDzEQGWvoycVsLZNxowJriSrI7kDua0AtLdbk4--lOzgDFKuwrO93YLz7z15-k_Sz9CduMwKAqF4z1FtOS_ci6CbLe3L9T_4E3DENmM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+Value+and+Prognostic+Significance+of+Pleural+C-Reactive+Protein+in+Lung+Cancer+Patients+with+Malignant+Pleural+Effusions&rft.jtitle=Yonsei+medical+journal&rft.au=%EB%B0%95%EB%8F%84%EC%8B%AC&rft.au=%ED%99%A9%EA%B8%B0%EC%9D%80&rft.au=%ED%99%A9%EC%9C%A0%EB%A6%AC&rft.au=%EB%B0%95%EC%B2%A0&rft.date=2013-03-01&rft.pub=%EC%97%B0%EC%84%B8%EB%8C%80%ED%95%99%EA%B5%90%EC%9D%98%EA%B3%BC%EB%8C%80%ED%95%99&rft.issn=0513-5796&rft.eissn=1976-2437&rft.spage=396&rft.epage=402&rft_id=info:doi/10.3349%2Fymj.2013.54.2.396&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_331280
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon